(Q52958869)

English

Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta.

scientific article published on 21 January 2015

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25773149

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/25773149

title

Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25773149

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/25773149

1 reference

Arno Hänninen

2

0 references

Jorma Ilonen

object named as

Jorma Ilonen

series ordinal

3

0 references

author name string

Julia Åivo

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25773149

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/25773149

Merja Soilu-Hänninen

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25773149

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/25773149

publication date

21 January 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25773149

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/25773149

published in

Journal of Neuroimmunology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25773149

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/25773149

volume

280

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25773149

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/25773149

page(s)

12-15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25773149

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/25773149

Identifiers

DOI

10.1016/J.JNEUROIM.2015.01.005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25773149

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/25773149

PubMed publication ID

25773149

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25773149

retrieved

9 May 2018

reference URL

http://europepmc.org/abstract/MED/25773149

(Q52958869)

Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)